Cited by 225Nicotinic Acetylcholine Receptors StudyNeuroscience and Neuropharmacology ResearchSmoking Behavior and Cessation

The DOI matches its Crossref record; 167 of the 176 references it cites were found in a registry or an index.

Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications

Open access

Abstract

Nicotinic acetylcholine receptors (nAChRs) in the muscle, autonomic ganglia, and brain are targets for pharmacologically administered nicotine. Several of the subunits that combine to form neuronal nicotinic receptors have been deleted by knockout or mutated by knockin in mice using homologous recombination. We will review the biochemical, pharmacological, anatomical, physiological, and behavioral phenotypes of mice with genetically altered neuronal nAChR subunits. Clinically relevant mutations in nAChR genes will also be discussed. In addition, some of the signal transduction pathways activated through nAChRs will be described in order to delineate the longer-term changes that might result from persistent activation or inactivation of nAChRs. Genetically manipulated mice have greatly increased our understanding of the subunit composition and physiological properties of nAChRs in vivo. In addition, these mice have provided a model system to determine the molecular basis for many of the pharmacological actions of nicotine on neurotransmitter release and behavior. Genetic manipulations in mice have also elucidated the role of nAChR subunits in various disease states, and suggest several avenues for drug development.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0163-7258(01)00161-9

Cites

167 of 167 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 176 references

Research works printed but not linked: 7

  1. Booker, 2000, Analysis of nicotinic receptors containing beta3 subunits in the regulation of anxiety using the beta3 null mutant mice, Soc Neurosci Abstr, 26, 1405
  2. Grady, 2000, Characterization of dopamine release mediated by the nicotinic acetylcholine receptor inhibited by α-conotoxin MII, Soc Neurosci Abstr, 26, 901
  3. Leonard, 1998, Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH Genetics Initiative, Am J Med Genet, 81, 308, 10.1002/(SICI)1096-8628(19980710)81:4<308::AID-AJMG6>3.0.CO;2-P · DOI
  4. Luo, 2000, α3β2β3 Nicotinic acetylcholine receptors, Soc Neurosci Abstr, 26, 22
  5. Riley, 1997, Further suggestive evidence for involvement of the α7-nicotinic cholinergic receptor gene on chromosome 15q13-q14 in schizophrenia, Am J Hum Genet, 61, A402
  6. Rollins, 1993, Reduction in auditory gating following intra-cerebroventricular application of α-bungarotoxin binding site ligands and α-7 antisense oligonucleotides, Soc Neurosci Abstr, 19, 837
  7. Xu, 1997, Gene targeting of the α7 and β2 subunits and the β4, α3, and α5 cluster of neuronal nicotine acetylcholine receptors, Soc Neurosci Abstr, 23, 391

Cited by

Sorted by citations

Items 201–225 of 225

Metadata

Authors
Picciotto, M. R., Caldarone, B. J., Brunzell, D. H., Zachariou, V., Stevens, T. R., & King, S. L.
Affiliations
Yale University (US)
Corresponding author
Picciotto, Marina R
Venue
Pharmacology & Therapeutics
Publisher
Elsevier BV
Published
2001-11
Volume
92
Issue
2-3
Pages
89-108
ISSN
0163-7258 (ISSN-L)
OpenAlex
W2053266420
Cited by
221
References
176
Citations by year
2026: 2 · 2025: 3 · 2024: 11 · 2023: 5 · 2022: 3 · 2021: 6 · 2020: 6 · 2019: 6 · 2018: 5 · 2017: 5 · 2016: 6 · 2015: 10 · 2014: 14 · 2013: 2 · 2012: 17
FWCI
0.62
Type
journal article
Language
en
Open access
Locations
  • Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
  • Sussex Research Online (University of Sussex) (submittedVersion)
Funders
  • National Institutes of Health
  • National Institute on Drug Abuse (DA 10455, DA84733, DA 00436)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords
neuronal nicotinic acetylcholine receptors, nicotine pharmacology, signal transduction, neurotransmitter release, behavioral phenotypes, physiological phenotypes, drug development
MeSH terms
Animals, Anxiety, Electrophysiology, Learning, Memory, Neurons, Nicotine, Phenotype, Receptors, Nicotinic, Signal Transduction, Point Mutation, Mice, Knockout, Nicotinic Agonists, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review